Olympus America, a Center Valley, Pa.-based commercial camera and medical supply maker, landed a contract to supply surgical tools to members of group purchasing organization Premier healthcare alliance.
Olympus
Olympus Medical wins FDA clearance for HD 3D surgical system
Sony picks up 11% Olympus stake for $640M | Wall Street Beat
Sony Corp. (TYO:6758) plans to become the largest shareholder in Olympus (TYO:7733) with a $642 million investment that will give it an 11% stake in Olympus.
Buyout: Terumo aims to merge with a post-scandal Olympus Corp.
Asian medical device giant Terumo Corp. (TYO:4543) confirmed rumors of a proposed buyout of Olympus (PINK:OCPNY) in the aftermath of a $1.7 billion accounting scandal.
Stryker to begin New York layoffs ahead of the medical device tax | Wall Street Beat
Panasonic denies investment in troubled Olympus | Wall Street Beat
Lost lawsuit pushes HemCon Medical into bankruptcy | Wall Street Beat
HemCon Medical Technologies said it’s filing for Chapter 11 bankruptcy protection for its U.S. operation after losing a $34.2 million court decision last month, saying it plans to appeal the ruling.
In March a sharply split U.S. Court of Appeals for the Federal Circuit reversed course and reinstated a win for Marine Polymer Technologies in its wound dressing patent spat with HemCon.
Post-scandal Olympus gets offers from Terumo, Fujifilm, Sony | MassDevice.com On Call
Florida cancer docs, treatment centers sued for $3.5 million in Medicare fraud | MassDevice.com On Call
MASSDEVICE ON CALL — The U.S. Government accused 2 Florida radiation oncologists and a group of treatment centers of defrauding state and government health programs for more than $3.5 million by conducting unnecessary procedures and lying about them.
Since at least December 2007 and continuing through October 2011 the defendants allegedly billed Medicare and other health services for "unreasonable, unnecessary, or medically improper radiation diagnosis treatments provided to patients without complying with the regulations, protocols, and requirements for reimbursement."
Analyst: CRM market “bad as it’s ever been” | Wall Street Beat
The cardiac rhythm management market is "about as bad as it has ever been," according to an analyst with Gabelli & Co., due in part to headwinds from a federal probe and a negative journal article.
MassDevice.com +7 | The top 7 med-tech stories for the week of February 27, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.